Xtandi
Ended Awarded
- Contract number
- VA24817F0184
- Awardee
-
Astellas Pharma US, Inc. UEI NKGHPQKJQWC1
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $243,162
Award facts
- Contract value 100% obligated
- $243,162.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- 112 Calle Arzuaga Ste 1, San Juan, 00925, Puerto Rico
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the oncology drug XTANDI under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract. The delivery order has a firm fixed price of $243,162.00 and an ultimate completion date of December 30, 2016. This order was placed under a larger $3.5 billion FSS contract awarded by the VA in 2021 to provide a wide range of pharmaceuticals and hematology-related products to VA medical facilities. Astellas also holds Blanket Purchase Agreements with the VA to facilitate purchases of XTANDI and other oncology drugs, with potential values up to $1 million. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract VA24817F0184?
VA24817F0184 was awarded to Astellas Pharma US, Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on December 1, 2016.
How much is contract VA24817F0184 worth?
The government has obligated $243,162 on VA24817F0184.
Is contract VA24817F0184 an order under another contract?
Yes. VA24817F0184 is a delivery order under V797D30296, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA24817F0184 competed?
The extent of competition for VA24817F0184 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award